Get startedLog in
    Picture of Heidelberg Pharma AG logo

    HPHA — Heidelberg Pharma AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Heidelberg Pharma: Partner Telix Pharmaceuticals Files Phase III Trial For Kidney Cancer Imaging In Europe

    Picture of Heidelberg Pharma AG logoHeidelberg Pharma AG
    23/08/2018 08:02
    Aug 23 (Reuters) - HEIDELBERG PHARMA AG  WL6G.DE :
    * PARTNER TELIX PHARMACEUTICALS FILES PHASE III TRIAL FOR
KIDNEY
CANCER IMAGING IN EUROPE

Source text for Eikon:  ID:nEQ9srZY0a 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Heidelberg Pharma AG

    See all news